Rhodiola rosea L. as a putative botanical antidepressant
- PMID: 27013349
- DOI: 10.1016/j.phymed.2016.02.009
Rhodiola rosea L. as a putative botanical antidepressant
Abstract
Background: Rhodiola rosea (R. rosea) is a botanical adaptogen with putative anti-stress and antidepressant properties. Evidence-based data supporting the effectiveness of R. rosea for depression in adults is limited, and therefore a comprehensive review of available animal and human studies suggesting a putative antidepressant action is warranted.
Purpose: A review of the literature was undertaken to ascertain studies of possible antidepressant mechanisms of action and studies of the safety and effectiveness of R. rosea extracts in animals and adult humans.
Methods: A search of MEDLINE and the Russian state library database was conducted (up to October 2015) on R. rosea.
Mechanism of action: R. rosea extracts and its purified constituent, salidroside, has been shown to produce a variety of mediator interactions with several molecular networks of neuroendocrine-immune and neurotransmitter receptor systems likely to be involved in the pathophysiology of depression. A wide variety of preclinical in vivo and ex vivo studies with laboratory animals suggests the presence of several biochemical and pharmacological antidepressant-like actions.
Effectiveness: Clinical assessment of R. rosea L. rhizome extracts in humans with various depressive syndromes is based upon results from two randomized, double-blind, placebo-controlled trials of 146 subjects with major depressive disorder and seven open-label studies totaling 714 individuals with stress-induced mild depression (diagnosed as asthenic syndrome or psychoneurosis). Overall, results of these studies suggests a possible antidepressant action for R. rosea extract in adult humans.
Safety: In contrast to most conventional antidepressants, R. rosea extract appears to be well-tolerated in short-term studies with a favorable safety profile.
Conclusions: R. rosea demonstrates multi-target effects on various levels of the regulation of cell response to stress, affecting various components of the neuroendocrine, neurotransmitter receptor and molecular networks associated with possible beneficial effects on mood.
Keywords: Clinical study; Molecular networks; Pharmacology; Rhodiola rosea L., Depression.
Copyright © 2016. Published by Elsevier GmbH.
Similar articles
-
Rhodiola rosea versus sertraline for major depressive disorder: A randomized placebo-controlled trial.Phytomedicine. 2015 Mar 15;22(3):394-9. doi: 10.1016/j.phymed.2015.01.010. Epub 2015 Feb 23. Phytomedicine. 2015. PMID: 25837277 Free PMC article. Clinical Trial.
-
Adaptogenic and central nervous system effects of single doses of 3% rosavin and 1% salidroside Rhodiola rosea L. extract in mice.Phytother Res. 2007 Jan;21(1):37-43. doi: 10.1002/ptr.2013. Phytother Res. 2007. PMID: 17072830
-
Salidroside, a Bioactive Compound of Rhodiola Rosea, Ameliorates Memory and Emotional Behavior in Adult Mice.J Alzheimers Dis. 2016 Feb 26;52(1):65-75. doi: 10.3233/JAD-151159. J Alzheimers Dis. 2016. PMID: 26967223
-
Rosenroot (Rhodiola rosea): traditional use, chemical composition, pharmacology and clinical efficacy.Phytomedicine. 2010 Jun;17(7):481-93. doi: 10.1016/j.phymed.2010.02.002. Epub 2010 Apr 7. Phytomedicine. 2010. PMID: 20378318 Review.
-
Anti-inflammatory effects of Rhodiola rosea L.: A review.Biomed Pharmacother. 2020 Jan;121:109552. doi: 10.1016/j.biopha.2019.109552. Epub 2019 Nov 9. Biomed Pharmacother. 2020. PMID: 31715370 Review.
Cited by
-
Combination of Stem Cells with Chinese Herbs for Secondary Depression in Neurodegenerative Diseases Based on Traditional Chinese Medicine Theories.Evid Based Complement Alternat Med. 2022 Mar 3;2022:6847917. doi: 10.1155/2022/6847917. eCollection 2022. Evid Based Complement Alternat Med. 2022. PMID: 35280507 Free PMC article. Review.
-
Review of the Efficacy and Mechanisms of Traditional Chinese Medicines as a Therapeutic Option for Ionizing Radiation Induced Damage.Front Pharmacol. 2021 Feb 15;12:617559. doi: 10.3389/fphar.2021.617559. eCollection 2021. Front Pharmacol. 2021. PMID: 33658941 Free PMC article. Review.
-
Evolution of the adaptogenic concept from traditional use to medical systems: Pharmacology of stress- and aging-related diseases.Med Res Rev. 2021 Jan;41(1):630-703. doi: 10.1002/med.21743. Epub 2020 Oct 25. Med Res Rev. 2021. PMID: 33103257 Free PMC article. Review.
-
Evaluation of Two Major Rhodiola Species and the Systemic Changing Characteristics of Metabolites of Rhodiola crenulata in Different Altitudes by Chemical Methods Combined with UPLC-QqQ-MS-Based Metabolomics.Molecules. 2020 Sep 5;25(18):4062. doi: 10.3390/molecules25184062. Molecules. 2020. PMID: 32899531 Free PMC article.
-
Rhodiola rosea L.: an herb with anti-stress, anti-aging, and immunostimulating properties for cancer chemoprevention.Curr Pharmacol Rep. 2017 Dec;3(6):384-395. doi: 10.1007/s40495-017-0106-1. Epub 2017 Sep 14. Curr Pharmacol Rep. 2017. PMID: 30393593 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials